Since vascular impairment has been shown to be involved in Aβ accumulation and AD progression [42], we then examined the vascular effects of SCF + G-CSF treatment through the analysis of vascular density in the brains of aged APP/PS1 mice. Here, APP is linked to Alzheimer disease.